The apoAI-CIII-AIV gene cluster

Area of Science:

• Genetics
• Cardiovascular Disease
• Biochemistry

Background:

• The apolipoprotein AI-CIII-AIV gene cluster is crucial for lipid metabolism.
• Genetic variations within this cluster have been linked to plasma lipid traits for over 15 years.
• Previous research primarily focused on the apoC-III gene's 3' untranslated region (SstI polymorphism) and its association with plasma triglycerides.

Purpose of the Study:

• To review frequent genetic variants in the apoAI-CIII-AIV gene cluster.
• To discuss the impact of these variants on plasma lipid traits.
• To explore associations between these genetic variants and coronary artery disease risk.

Main Methods:

• Literature review of studies on apoAI-CIII-AIV gene cluster variations.
• Analysis of associations between specific polymorphisms (SstI, Msp-AI) and lipid profiles.
• Examination of correlations with coronary artery disease risk.

Main Results:

• The apoC-III SstI polymorphism is consistently associated with plasma triglyceride levels, though results vary across studies.
• The apoA-I gene promoter Msp-AI polymorphism (-75 position) is linked to variations in plasma apoA-I and HDL-cholesterol levels.
• Certain genetic variants in the apoAI-CIII-AIV cluster show associations with an increased risk of developing coronary artery disease.

Conclusions:

• Genetic variations in the apoAI-CIII-AIV gene cluster significantly influence plasma lipid levels.
• Specific polymorphisms, notably apoC-III SstI and apoA-I Msp-AI, are key determinants of lipid profiles.
• These genetic factors contribute to the understanding of coronary artery disease pathogenesis.